1
|
Yamada K, Masuda Y. A sulfur-33 nuclear quadrupole resonance study of 33 S 2 -labeled L-cystine. MAGNETIC RESONANCE IN CHEMISTRY : MRC 2023; 61:296-300. [PMID: 36650107 DOI: 10.1002/mrc.5333] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/20/2022] [Revised: 01/11/2023] [Accepted: 01/14/2023] [Indexed: 06/17/2023]
Abstract
The sulfur electric-field-gradient tensor for a disulfide bond in 33 S2 -labeled L-cystine has been investigated by 33 S nuclear quadrupole resonance (NQR). 33 S2 -labeled L-cystine is synthesized by introduction of disulfide ions prepared from elemental 33 S-sulfur into an amino acid derivative, the side chain of which is iodinated. In its NQR spectrum, sharp single peaks are observed at between 24.63 and 24.90 MHz in the temperature range from 80 to 298 K. The two-dimensional nutation echo 33 S NQR experiment is carried out at 160 K, and the quadrupole coupling constant, CQ , and the asymmetric parameter, ηQ , are obtained to be 46.9(9) MHz and 0.6(1), respectively. The calculated 33 S electric-field-gradient tensor components with respect to the molecular frame is briefly discussed.
Collapse
Affiliation(s)
- Kazuhiko Yamada
- Interdisciplinary Science Unit, Multidisciplinary Sciences Cluster, Research and Education Faculty, Kochi University, Kochi, Japan
| | - Yuichi Masuda
- Graduate School of Bioresources, Mie University, Tsu, Japan
- Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan
| |
Collapse
|
2
|
Zhang S, Chen Y, Zhu J, Lu Q, Cryle MJ, Zhang Y, Yan F. Structural diversity, biosynthesis, and biological functions of lipopeptides from Streptomyces. Nat Prod Rep 2023; 40:557-594. [PMID: 36484454 DOI: 10.1039/d2np00044j] [Citation(s) in RCA: 16] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Covering: up to 2022Streptomyces are ubiquitous in terrestrial and marine environments, where they display a fascinating metabolic diversity. As a result, these bacteria are a prolific source of active natural products. One important class of these natural products is the nonribosomal lipopeptides, which have diverse biological activities and play important roles in the lifestyle of Streptomyces. The importance of this class is highlighted by the use of related antibiotics in the clinic, such as daptomycin (tradename Cubicin). By virtue of recent advances spanning chemistry and biology, significant progress has been made in biosynthetic studies on the lipopeptide antibiotics produced by Streptomyces. This review will serve as a comprehensive guide for researchers working in this multidisciplinary field, providing a summary of recent progress regarding the investigation of lipopeptides from Streptomyces. In particular, we highlight the structures, properties, biosynthetic mechanisms, chemical and chemoenzymatic synthesis, and biological functions of lipopeptides. In addition, the application of genome mining techniques to Streptomyces that have led to the discovery of many novel lipopeptides is discussed, further demonstrating the potential of lipopeptides from Streptomyces for future development in modern medicine.
Collapse
Affiliation(s)
- Songya Zhang
- CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
| | - Yunliang Chen
- Helmholtz International Lab for Anti-Infectives, Shandong University-Helmholtz Institute of Biotechnology, State Key Laboratory of Microbial Technology, Shandong University, Qingdao, Shandong 266237, China.
- The Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 1000050, China.
| | - Jing Zhu
- CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
| | - Qiujie Lu
- Helmholtz International Lab for Anti-Infectives, Shandong University-Helmholtz Institute of Biotechnology, State Key Laboratory of Microbial Technology, Shandong University, Qingdao, Shandong 266237, China.
| | - Max J Cryle
- Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, 3800 Australia
- EMBL Australia, Monash University, Clayton, Victoria, 3800 Australia
- ARC Centre of Excellence for Innovations in Peptide and Protein Science, Monash University, Clayton, Victoria, 3800 Australia
| | - Youming Zhang
- CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
- Helmholtz International Lab for Anti-Infectives, Shandong University-Helmholtz Institute of Biotechnology, State Key Laboratory of Microbial Technology, Shandong University, Qingdao, Shandong 266237, China.
| | - Fu Yan
- Helmholtz International Lab for Anti-Infectives, Shandong University-Helmholtz Institute of Biotechnology, State Key Laboratory of Microbial Technology, Shandong University, Qingdao, Shandong 266237, China.
| |
Collapse
|
3
|
Rassias G, Hermitage SA, Sanganee MJ, Kincey PM, Smith NM, Andrews IP, Borrett GT, Slater GR. Development of a Supply Route for the Synthesis of an iNOS Inhibitor: Complications of the Key SN2 Reaction. Org Process Res Dev 2009. [DOI: 10.1021/op900108b] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Geracimos Rassias
- GlaxoSmithKline R&D, Chemical Development, Synthetic Chemistry, Gunnels Wood Rd, Stevenage, Hertfordshire SG1 2NY, U.K
| | - Stephen A. Hermitage
- GlaxoSmithKline R&D, Chemical Development, Synthetic Chemistry, Gunnels Wood Rd, Stevenage, Hertfordshire SG1 2NY, U.K
| | - Mahesh J. Sanganee
- GlaxoSmithKline R&D, Chemical Development, Synthetic Chemistry, Gunnels Wood Rd, Stevenage, Hertfordshire SG1 2NY, U.K
| | - Peter M. Kincey
- GlaxoSmithKline R&D, Chemical Development, Synthetic Chemistry, Gunnels Wood Rd, Stevenage, Hertfordshire SG1 2NY, U.K
| | - Neil M. Smith
- GlaxoSmithKline R&D, Chemical Development, Synthetic Chemistry, Gunnels Wood Rd, Stevenage, Hertfordshire SG1 2NY, U.K
| | - Ian P. Andrews
- GlaxoSmithKline R&D, Chemical Development, Synthetic Chemistry, Gunnels Wood Rd, Stevenage, Hertfordshire SG1 2NY, U.K
| | - Gary T. Borrett
- GlaxoSmithKline R&D, Chemical Development, Synthetic Chemistry, Gunnels Wood Rd, Stevenage, Hertfordshire SG1 2NY, U.K
| | - Graham R. Slater
- GlaxoSmithKline R&D, Chemical Development, Synthetic Chemistry, Gunnels Wood Rd, Stevenage, Hertfordshire SG1 2NY, U.K
| |
Collapse
|